User profiles for Avindra Nath

Avindra Nath

National Institute of Neurological Diseases and Stroke
Verified email at ninds.nih.gov
Cited by 49287

[HTML][HTML] Microvascular injury in the brains of patients with Covid-19

…, J Moncur, M Hefti, RD Folkerth, A Nath - … England Journal of …, 2021 - Mass Medical Soc
Microvascular Changes in the Brain in Covid-19 High-resolution MRI and histopathological
study of the brains of patients who had died from Covid-19 showed punctate hyperintensities …

Neurologic complications of coronavirus infections

A Nath - Neurology, 2020 - AAN Enterprises
… We read with interest the editorial by Avindra Nath. Stroke is briefly mentioned and it is
not included in the table that summarizes the clinical syndromes associated with SARS-CoV-2 …

Nervous system consequences of COVID-19

S Spudich, A Nath - Science, 2022 - science.org
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a
respiratory pathogen, myriad neurologic complications—including confusion, stroke, and …

[HTML][HTML] ANA investigates: neurological complications of COVID‐19 vaccines

AL Goss, RD Samudralwar, RR Das, A Nath - Annals of neurology, 2021 - ncbi.nlm.nih.gov
As more patients gain access to the coronavirus disease 2019 (COVID-19) vaccines,
neurologists are facing questions about potential neurological complications, benefits, and timing …

Neurovascular injury with complement activation and inflammation in COVID-19

…, MN Stram, JT Moncur, M Hefti, RD Folkerth, A Nath - Brain, 2022 - academic.oup.com
The underlying mechanisms by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
leads to acute and long-term neurological manifestations remains obscure. We …

[HTML][HTML] Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti …

…, ML Wang, CC Chen, SM Kranick, A Nath… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose T cells can be genetically modified to express an anti-CD19 chimeric antigen
receptor (CAR). We assessed the safety and efficacy of administering autologous anti-CD19 …

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

…, M Alimchandani, AZ Rosenberg, A Nath… - Journal of …, 2013 - journals.lww.com
Nine cancer patients were treated with adoptive cell therapy using autologous anti-MAGE-A3
T-cell receptors (TCR)-engineered T cells. Five patients experienced clinical regression of …

[PDF][PDF] Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation

…, DP Perl, S Liddelow, R Folkerth, D Putrino, A Nath… - Cell, 2022 - cell.com
COVID survivors frequently experience lingering neurological symptoms that resemble
cancer-therapy-related cognitive impairment, a syndrome for which white matter microglial …

A full genome search in multiple sclerosis

…, P Duquette, S Warren, T Gray, P O'Connor, A Nath… - Nature …, 1996 - nature.com
The aetiology of multiple sclerosis (MS) is uncertain. There is strong circumstantial evidence
to indicate it is an autoimmune complex trait 1–3 . Risks for first degree relatives are …

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

…, DM Simpson, G Arendt, G Giovannoni, A Nath - The Lancet …, 2010 - thelancet.com
Background Treatment of multiple sclerosis with natalizumab is complicated by rare
occurrence of progressive multifocal leukoencephalopathy (PML). Between July, 2006, and …